Sexual Medicine Society of North America, Inc.

Scientific Program - Friday, November 20, 2015

Session type:
Person:
Clear filters

Morning

07:00 a.m. - 08:00 a.m.
Industry Sponsored Breakfast
Location: Mouton


08:00 a.m. - 09:00 a.m.
Surgery for Female Sexual Concerns
Location: Latour Ballroom 2
Moderators: Seth Cohen, MD, MPH & Michael Krychman, MD

08:00 a.m. - 08:20 a.m.
Reconstruction after FGC
Crista E. Johnson-Agbakwu, MD, MSc

08:20 a.m. - 08:40 a.m.
Management of Sexual Pain
Irwin Goldstein, MD

08:40 a.m. - 09:00 a.m.
Cosmetic Genital Surgery
Christine Hamori, MD


09:00 a.m. - 09:30 a.m.
History of Penile Surgery for ED
Location: Latour Ballroom 2
Moderators: William O. Brant, MD & Lawrence S. Hakim, MD, FACS

09:00 a.m. - 09:15 a.m.
History of Vascular Surgery for ED
Ronald Virag, MD

09:15 a.m. - 09:30 a.m.
History of Prosthetic Surgery: F. Brantley Scott ED
David F. Mobley, MD


09:30 a.m. - 09:45 a.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


09:45 a.m. - 10:30 a.m.
Using Social Media to Promote your Practice
Location: Latour Ballroom 2
Moderator: Andrew C. Kramer, MD

09:45 a.m. - 10:00 a.m.
Using Social Media to Promote your Practice
Brian Steixner, MD

10:00 a.m. - 10:30 a.m.
Using Social Media to Promote your Practice
Farris K. Timimi, MD


10:30 a.m. - 11:30 a.m.
Medicolegal Issues in Sexual Medicine
Location: Latour Ballroom 2
Moderator: John Mulhall, MD

10:30 a.m. - 10:40 a.m.
How to Minimize Complications and Litigation in Penile Surgery
David Ralph, MS, FRCS

10:40 a.m. - 10:55 a.m.
The Anatomy of a Lawsuit – Avoiding Pitfalls
Mark E. Nichols, Esq.

10:55 a.m. - 11:10 a.m.
Mindset for Suit Survival
Luis Quintero, MD, FACEP

11:10 a.m. - 11:30 a.m.
Q&A


11:30 a.m. - 11:55 p.m.
AUA Update
Location: Latour Ballroom 2

11:30 a.m. - 11:45 p.m.
AUA Secretary Address
Manoj Monga, MD, FACS

11:45 a.m. - 11:55 a.m.
AUA Update - Research
Carolyn Best, PhD


11:55 a.m. - 12:00 p.m.
JSM Update
Location: Latour Ballroom 2
Moderator: John Mulhall, MD


Afternoon

12:00 p.m. - 01:30 p.m.
Special SMSNA Lunch Symposium on Hypogonadism (Independent Satellite Symposium, CME-certified)
Location: Mouton


01:30 p.m. - 02:30 p.m.
ESSM Symposium on Peyronie’s Disease: What’s next?
Location: Latour Ballroom 2
Moderator: David Ralph, MS, FRCS

01:30 p.m. - 01:47 p.m.
Phenotypic Screening for Peyronie's Disease: A new hope for new therapeutics?
Selim Cellek, MD, PhD

01:47 p.m. - 02:04 p.m.
Patients bother in Peyronie's Disease
Yacov Reisman, MD, PhD

02:04 p.m. - 02:19 p.m.
The 2015 ICSM Guidelines for Peyronie’s Disease
David Ralph, MS, FRCS

02:20 p.m. - 02:30 p.m.
Minimally Invasive Treatment of PD with PRP and Hyaluronic Acid
Ronald Virag, MD


01:30 p.m. - 02:30 p.m.
Use of Androgens in Women
Location: Margaux 1
Moderators: Irwin Goldstein, MD & Michael Krychman, MD

01:30 p.m. - 01:50 p.m.
Actions of Testosterone in Women
Noel N. Kim, PhD

01:50 p.m. - 02:10 p.m.
Testosterone Therapy in Women: The Evidence
Sharon J. Parish, MD, IF, NCMP

02:10 p.m. - 02:30 p.m.
Testosterone in Women with History of Gyne/Breast Cancers
Mindy E. Goldman, MD


01:30 p.m. - 02:30 p.m.
Basic Science of Priapism: New Paradigms
Location: Margaux 2
Moderators: Arthur L. Burnett II, MD & Biljana Musicki, PhD

01:30 p.m. - 02:00 p.m.
Pathophysiology of Priapism
Kelvin Davies, BSc, MSc, PhD

02:00 p.m. - 02:30 p.m.
Clinical Applications of Basic Science in Priapism
Arthur L. Burnett II, MD


01:30 p.m. - 04:00 p.m.
APN-PA Hands-on Stations
Location: Lafleur 2
Moderator: Kenneth Mitchell, MPAS, PA-C

01:30 p.m. - 02:00 p.m.
Testopel
Peter Veneziano, PA

02:00 p.m. - 02:30 p.m.
Xiaflex
Joseph B. Narus, DNP, APRN, NP-BC

02:30 p.m. - 03:00 p.m.
Coding
Susanne Talebian, CHBC, RMM, CMOM, CPC-I, CPC, CUA, CCS-P, PCS

03:00 p.m. - 03:30 p.m.
Penile Injections
Kevin Flinn, RN

03:30 p.m. - 04:00 p.m.
Male Genital Exam
Jeffrey Albaugh, PhD, APRN, CUCNS


02:30 p.m. - 03:00 p.m.
Off Label Management of Testosterone Deficiency
Location: Latour Ballroom 2
Moderators: Andrew R. McCullough, MD & Charles Welliver, MD

02:30 p.m. - 02:45 p.m.
Anastrazole
Alexander W. Pastuszak, MD, PhD

02:45 p.m. - 03:00 p.m.
HCG
Landon W. Trost, MD


02:30 p.m. - 04:00 p.m.
Moderated Posters: Basic Science I
Location: Margaux 2
Moderators: Kelvin Davies, BSc, MSc, PhD & Johanna Hannan, PhD

02:30 p.m. - 02:37 p.m.
Neuronal and Sonic Hedgehog Regulation of Collagen Abundance and Development in the Penis (#014)
Carol A. Podlasek, PhD

02:37 p.m. - 02:44 p.m.
Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary Artery Dysfunction in Young Lewis Rats (#015)
C.J. Wingard

02:44 p.m. - 02:51 p.m.
Development of a High-Throughput, Cell-Based Assay for Anti-Myofibroblast Activity in Peyronie’s Disease (#016)
M. Mateus

02:51 p.m. - 02:58 p.m.
Development of Gene Therapy for Erectile Dysfunction: Delivery to Corpus Cavernosa using Viral Vectors (#017)
R. Terlecki

02:58 p.m. - 03:05 p.m.
Mirabegron Elicits Smooth Muscle Relaxation of Human and Rat Corpus Cavernosum Tissues via Non Nitric Oxide-cGMP Pathways (#018)
F.A. Yafi

03:05 p.m. - 03:12 p.m.
Vascular Endothelial Growth Factor and Antioxidants Improve Erectile Function in Diabetic Rats (#019)
L. DeYoung

03:12 p.m. - 03:19 p.m.
Regulation of Sphingosine-1-Phosphate (S1P) Signaling Pathway in Rats and Humans and Alterations in Response to Pathologically-Induced Erectile Dysfunction (#020)
Michael E. DiSanto, PhD

03:19 p.m. - 03:26 p.m.
SDF-1 Treatment Promotes Neurite Outgrowth from the Major Pelvic Ganglion by Upregulating Neurotrophins (#021)
Nikolai Sopko, MD, PhD

03:26 p.m. - 03:33 p.m.
Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Pathogenesis of Peyronie’s Disease (#022)
L. DeYoung

03:33 p.m. - 03:40 p.m.
Harnessing the Role of Microtubules in Neural Regeneration to Improve Erectile Function Outcomes Following Cavernous Nerve Injury in a Rat Model of Radical Prostatectomy (#023)
Kelvin Davies, BSc, MSc, PhD

03:40 p.m. - 03:47 p.m.
TNF-alpha Inhibits Neurite Outgrowth from the Major Pelvic Ganglion by Inducing Apoptosis of Nitrergic Neurons Ex Vivo (#024)
H. Matsui

03:47 p.m. - 03:54 p.m.
New Methodology for Investigating Ejaculation Dysfunction: Measuring Intraluminal Seminal Vesicle Pressure in Rats with Telemetric Device (#025)
S.W. Lee

03:54 p.m. - 04:00 p.m.
The Effect of Dietary Iron Intake on Intratesticular Metal Concentrations (#026)
J.S. Gabrielsen


03:00 p.m. - 04:00 p.m.
Moderated Posters: Androgens I
Location: Latour Ballroom 2
Moderators: Selim Cellek, MD, PhD & Abraham Morgentaler, MD

03:00 p.m. - 03:05 p.m.
Diagnostic Accuracy of a Single Serum Testosterone Measurement: The False Negative Rate (#027)
X. Ni

03:05 p.m. - 03:10 p.m.
Efficacy and Pharmacokinetics of Oral Testosterone (LPCN 1021) in Hypogonadal Men (#028)
Irwin Goldstein, MD

03:10 p.m. - 03:15 p.m.
Testosterone Solution 2% for Erectile, Orgasmic and Ejaculatory Dysfunction in Hypogonadal Men (#029)
D.A. Paduch

03:15 p.m. - 03:20 p.m.
Dose Titration and Safety of Oral Testosterone in Hypogonadal Men: Results from the SOAR Study (#030)
Mohit Khera, MD

03:20 p.m. - 03:25 p.m.
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study (#031)
Gerald B. Brock, MD

03:25 p.m. - 03:30 p.m.
The Construct Validity of the Patient-Reported Outcome Instruments Sexual Arousal, Interest, and Drive Scale (SAID) and the Hypogonadism Energy Diary (HED) (#032)
D. Heiselman

03:30 p.m. - 03:35 p.m.
An Assessment Of The Impact Of Testosterone Supplementation Therapy On Hemoglobin A1C (HbA1C) Levels In Diabetic And Non-Diabetic Men (#033)
John Mulhall, MD

03:35 p.m. - 03:40 p.m.
Diagnostic Accuracy of a Single Serum Testosterone Measurement (#034)
X. Ni

03:40 p.m. - 03:45 p.m.
Improvement of Endothelial Function Following Initiation of Testosterone Replacement Therapy (#035)
D. Shoskes

03:45 p.m. - 03:50 p.m.
Assessment of Fasting and Varying Meal Fat Content on the Bioavailability of Oral Testosterone Undecanoate (LPCN 1021) in Hypogonadal Men (#036)
Mohit Khera, MD

04:45 p.m. - 04:50 p.m.
Twice Weekly Dosing of Injectable Testosterone Associated with Increased Erythrocytosis (#037)
S.J. Ohlander


04:00 p.m. - 05:00 p.m.
Industry Sponsored Reception
Location: Mouton


05:00 p.m. - 05:45 p.m.
ASMH Session
Location: Latour Ballroom 2
Moderators: Gregory A. Broderick, MD & Seth Cohen, MD, MPH

05:00 p.m. - 05:23 p.m.
Cardiovascular Disease and ED – How to Council Patients and What are the Next Steps
Martin Miner, MD

05:23 p.m. - 05:45 p.m.
Incorporating Cardiovascular Wellness/Men’s Health Promotion in Urologic Practice
Culley C. Carson III, MD, FACS, FRCS(hon)


05:00 p.m. - 06:00 p.m.
Moderated Posters: Priapism/Reconstruction
Location: Margaux 1
Moderators: Gerald B. Brock, MD & Robert C. Dean, MD

05:00 p.m. - 05:05 p.m.
Validation of the Priapism Profile Impact Questionnaire (#038)
B. Morrison

05:05 p.m. - 05:10 p.m.
A Retrospective Evaluation of the Safety and Effectiveness of a Silicone Block Implant for Elective Cosmetic Surgery of the Penis (#039)
O. Mirgoli

05:10 p.m. - 05:15 p.m.
Surgical Management of Acquired Buried Penis: Experience from Two Institutions (#040)
A. Herati

05:15 p.m. - 05:20 p.m.
Use of Phenylephrine in the Treatment of Ischemic Priapism: 5 year Experience at a Single Institution (#041)
D.G. Ridyard

05:20 p.m. - 05:25 p.m.
Buccal Mucosal Grafting in Peyronie’s Disease. Still not the Best (#042)
A. Zahran

05:25 p.m. - 05:30 p.m.
Complications and Surgical Management of Vaseline Injection Into the Penis for Girth Enhancement – A Photo Documentary: Support for the SMSNA’s Position on Penile Lengthening and Girth Enhancement. (#043)
Y. Krakowsky

05:30 p.m. - 05:35 p.m.
The Effect of Treatment for Priapism on Erectile Dysfunction (#044)
H. Levey Bernie

05:35 p.m. - 05:40 p.m.
Surgical Interventions for Priapism: The role of Penile Prostheses (#045)
M.J. Pagano

05:40 p.m. - 05:45 p.m.
Percutaneous Revision of a Testicular Prosthesis (#046)
M. Mendez

05:45 p.m. - 05:50 p.m.
Recovery of Glans Sensation Following Combined Dorsal and Ventral Onlay with a Glans Splitting Technique for Strictures of the Fossa Navicularis (#047)
M. Mendez

05:50 p.m. - 05:55 p.m.
Fertility Preservation in the Male to Female Transgender Patient: Role of Testis Sperm Extraction (TESE) and Testis Histology in Patients undergoing Gender Reassignment Surgery (#048)
S. Honig


05:00 p.m. - 06:00 p.m.
Moderated Posters: Epidemiology
Location: Margaux 2
Moderators: Maurice Garcia, MD, MAS & Mindy E. Goldman, MD

05:00 p.m. - 05:05 p.m.
Epidemiology of Penile Fractures in the Emergency Setting (#049)
S. Liu

05:05 p.m. - 05:10 p.m.
Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Intervention in Low-Risk Patients? (#050)
Lawrence C. Jenkins, MD, MBA

05:10 p.m. - 05:15 p.m.
Impact of Anal Sex Role on the HIV Protective Effect of Circumcision in MSM (#051)
D. Milam

05:15 p.m. - 05:20 p.m.
Testicular Torsion: Epidemiological Risk Factors for Orchiectomy in Pediatric and Adult Patients (#052)
G. Horn

05:20 p.m. - 05:25 p.m.
Evaluation of Doppler Parameters in Patients without Organic Erectile Dysfunction (#053)
Gregory A. Broderick, MD

05:25 p.m. - 05:30 p.m.
Post Finasteride Syndrome: Guess Who-Demographics from FDA Database (#054)
A. Lwin

05:30 p.m. - 05:35 p.m.
National Trends in the Diagnosis and Management of Psychogenic Erectile Dysfunction (#055)
D.J. Lee

05:35 p.m. - 05:40 p.m.
National Sex Survey in South Korea (#056)
D.G. Moon

05:40 p.m. - 05:45 p.m.
Changes in Erectile Dysfunction Over Time by age: A Community-Based Population Study (#057)
M.J. Ziegelmann

05:45 p.m. - 05:50 p.m.
Safe Space: LGBTQ training at the University of Miami (#058)
S. Kenya


Tweets about the meeting

Our Services

About SMSNA

Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
+1 (952) 683 1917
+1 (612) 808 0491
info@smsna.org

Address
14305 Southcross Dr
Suite 100
Burnsville MN, 55306